2011-05-16T15:22:46-00:00 2010-06-30 990 2009-07-01 232003072 Fox Chase Cancer Center FOXC 2157282457 333 Cottman Avenue Philadelphia PA 191112497 Thomas S Albanesi Jr 2011-05-13 false 2009 2016-02-24 21:20:13Z Michael V Seiden MD PhD 333 Cottman Avenue Philadelphia PA 19111 63058956 false X www.fccc.edu X 1963 DE The Mission of the Fox Chase Cancer Center is to Prevail over cancer, marshaling heart and mind in bold scientific discovery, pioneering prevention, and compassionate care. 25 24 842 58 0 39039928 31147599 13901106 14751363 2233001 1738173 684122 1632649 55858157 49269784 0 0 55839424 49394151 489619 619537 2487181 8169475 6378588 64498518 56392276 -8640361 -7122492 153087177 148936985 125470069 118248931 27617108 30688054 The Mission of the Fox Chase Cancer Center is to prevail over cancer, marshaling heart and mind in bold scientific discovery, pioneering prevention, and compassionate care. true false 26704567 14751363 Researchers at Fox Chase investigate problems that range from understanding the fundamental mechanisms of bimolecular reactions all the way to the treatment of neoplastic diseases in the clinic. The science is conducted with Fox Chases Commitment to research and interdisciplinary interaction. Current faculty research programs are wide-ranging and include Cancer Biology Identifying suitable targets for intervention in cancer and using this information to inform novel preclinical studies and clinical trials that target cooperating cancer-promoting pathways. Cancer Prevention and Control Integrating basic and applied research in the areas of chemoprevention, medical science, and the behavioral, social and population sciences. Immune Cell Development and Host Defense Focusing on the biology of immune cells-from how they develop to how they function, principally in the context of viral infections. Developmental Therapeutics Seeking to understand the fundamental Molecular events that drive cancer and utilize this knowledge to create new therapeutic agents and improve the application of existing agents. Womens Cancer Focusing on the development of translational studies of prevention, risk reduction, behavioral studies of prevention, risk reduction, behavioral medicine and treatment through interactions of basic science and investigators. 13789648 The research facilities have been structured to fulfill the needs of the multi-disciplinary research programs at Fox Chase Cancer Center. The facilities have been designed to enhance on-going research by supplying information, reagents, and technical expertise that are not readily available to the individual investigator. 40494215 true true false true false false false false true true false true false false false false false true true false false false false true true false false false false false false false false false true false true false false false true false false false true 0 0 842 true false false false false false false false false false false false false 25 24 false false false false false false false true true false true true false true true true true true true true false false PA NY NJ X Thomas S Albanesi 2157282457 604 Cottman Avenue Cheltenham PA 19012 Michael V Seiden MD PhD 040.00 X 530790 0 15973 Paul F Engstrom MD 040.00 X 431552 0 17465 Jeff Boyd PhD 040.00 X 421592 0 21796 J Robert Beck MD 040.00 X 364444 0 8849 Joseph F Hediger 040.00 X 311537 0 17095 Gary J Weyhmuller 040.00 X 311538 0 21545 Susan H Tofani 040.00 X 311496 0 5127 Robert G Wilkens 040.00 X 69231 0 175 Mary B Daly MD PhD 040.00 X 345309 0 10391 Anna Marie Skalka PhD 040.00 X 305785 0 17474 Jill L Marsteller 040.00 X 234548 0 13842 Robert C Young 040.00 X 206344 0 12472 R Donald Leedy 040.00 X 176102 0 0 Christine Wilson 040.00 X 146872 0 0 George R Simon 040.00 X 322993 0 18553 Jose Russo 040.00 X 246640 0 3591 Joseph R Testa 040.00 X 238195 0 8945 Suzanne M Miller Halegoua 040.00 X 237095 0 9925 Sharon L Manne 040.00 X 208756 0 9216 Virgil C Jordan 040.00 X 136538 0 6382 Dorothy A Riehs 040.00 X 248456 0 20150 Anthony Diasio 040.00 X 213922 0 17858 Joanne M Hambleton 040.00 X 207692 0 3669 Kurt Schwinghammer 040.00 X 181173 0 2647 Robert Spallone 040.00 X 186895 0 14377 Thomas K Garvey 040.00 X 149948 0 2887 Joseph A Piccolo 040.00 X 95980 0 10120 David G Marshall 005.00 X 0 0 0 W Thacher Brown 005.00 X 0 0 0 Louis E Della Penna Sr 005.00 X 0 0 0 Thomas W Hofmann 005.00 X 0 0 0 Margot W Keith 005.00 X 0 0 0 Peter McCausland 005.00 X 0 0 0 William J Avery 005.00 X 0 0 0 G Morris Dorrance Jr 005.00 X 0 0 0 The Honorable Dwight Evans 005.00 X 0 0 0 Edward A Glickman 005.00 X 0 0 0 Michael J Heller Esq 005.00 X 0 0 0 Lawrence T Hoyle Jr Esq 005.00 X 0 0 0 Philip E Lippincott 005.00 X 0 0 0 William G Little 005.00 X 0 0 0 Jill Michal 005.00 X 0 0 0 Donald E Morel Jr PhD 005.00 X 0 0 0 Jane G Pepper 005.00 X 0 0 0 Edward J Roach 005.00 X 0 0 0 Thomas Shenk PhD 005.00 X 0 0 0 Pamela Strisofsky 005.00 X 0 0 0 William Stulginsky 005.00 X 0 0 0 Thomas R Tritton PhD 005.00 X 0 0 0 Kenneth E Weg 005.00 X 0 0 0 Yoram Jerry Wind PhD 005.00 X 0 0 0 Zane Wolf PhD 005.00 X 0 0 0 Debra Sniger Ex Officio 005.00 X 0 0 0 Michael V Seiden MD PhD Ex Officio 005.00 X 0 0 0 6841423 290524 56 true true false P Agnes Inc 2101 Penrose Avenue Philadelphia PA 19145 Professional Services 8445475 FTI Healthcare PO Box 630391 Baltimore MD 21263 Professional Services 2229993 Harmelin Media 525 Righters Ferry Road Bala Cynwyd PA 19004 Professional Services 1908853 Mount Sinai School of Medicine 1 Gustave L Levy Place New York NY 10029 Professional Services 746705 Georgetown University 37th O Streets Box 571164 Washington DC 20057 Professional Services 620003 41 7748 31139851 31147599 Research Programs 14751363 14751363 14751363 8610 8610 -1843893 -1843893 17032352 13458896 3573456 3573456 3573456 447413 7748 216660 230753 230753 1421286 113616 1307670 1307670 Misc Revenue 900099 94226 94226 94226 49269784 14751363 3370822 0 0 0 0 6842056 2041939 4800117 0 30902609 19564700 9671753 1666156 433478 248141 166202 19135 8631679 5340267 2920885 370527 2584329 1479379 990870 114080 0 835795 9151 826644 60513 60513 0 619537 619537 0 4616302 3165454 1144096 306752 170102 88709 56552 24841 303528 105535 169049 28944 177069 177069 0 1811166 1529217 281949 600924 354822 230056 16046 0 291175 152941 117151 21083 2815402 879831 1935571 -22836366 1217053 -23589733 -463686 5706134 1783202 3922932 0 Purchase Services 11649775 2478539 9407470 -236234 Leases 177069 55335 121734 0 56392276 40494215 13410880 2487181 4480603 2215927 393147 231315 15441908 10275377 2690479 3178343 1749527 1543704 129254155 35870274 93840515 98203218 29961262 32449983 725197 420113 3804539 419005 153087177 148936985 16786769 13055614 9779623 9772632 72023649 70821072 14000000 14950000 12880028 9649613 125470069 118248931 X -19605915 -17486708 18785471 19716857 28437552 28457905 27617108 30688054 153087177 148936985 X false true true X true true X 57729263 52575222 50517563 50944471 45898962 257665481 57729263 52575222 50517563 50944471 45898962 257665481 257665481 787585 496676 1801099 -373244 -1835283 876833 258542314 5170846 0.99660 0.98740 X 0.00000 0.00000 Part I N/A Part II N/A Part III N/A RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 10600 50284 10600 50284 53894495 335334783 53905095 335385067 1000000 1000000 250000 250001 false 1000000 1000000 1000000 1000000 4000000 6000000 54667 57747 157246 50284 319944 250000 250000 250000 250001 1000001 1500002 false false false false false false false false false false false I-A 1 Management has had direct discussions with Congressional representatives to provide input on Health Care Reform matters. Such discussions included the role of Comprehensive Cancer Centers, payment issues affecting Cancer Hospitals, issues affecting beneficiary access to comprehensive cancer centers including the importance of maintaining coverage for clinical trials, importance of maintaining and strengthening funding levels for cancer research. I-A 1 Additionally, to assist the organization obtain needed funding for cutting edge technologies and resources utilized by the scientific and clinical faculty, the Center annually seeks federal support through various legislative appropriation mechanisms. This typically involves submission of a grant/proposals and may require ongoing dialogue and/or meetings with Congressional members and their staffs to discuss the merits of the proposals. I-A 1 Management also meets with and corresponds with members of the State House and Senate regarding the importance of ongoing funding to organizations that are involved in cancer research and how this funding contributes significantly to more favorable outcomes in the fight against cancer and with economic development. I-B Not Applicable I-C Not Applicable false 29961262 637869 2831787 555935 425000 32449983 48393986 3952028 -9589495 1669947 11125310 29961262 0.03000 0.80000 0.17000 false true true 350000 350000 43219057 23844726 88510832 512682 185942 344193 23323592 11839606 8200893 61848824 797300 98203218 420113 F 420113 Network Dynamis Equity 419005 F 419005 Post-Retirement Benefits 9291047 FAS 112 Costs 583000 Escheat Payable 8822 FAS 133 734047 Citizens MTM 15714838 Annuity Liability 574835 Asset Retirement Obligation 5297 Misc 7325 Affiliate Balance -17269598 9649613 49269784 56392276 -7122492 -1582210 13145615 -1369967 10193438 3070946 49863683 49863683 -593899 -593899 49269784 56392276 56392276 56392276 V 4 Appointment to an endowed chair rewards a scientists professional contributions, recognizes the value of his or her research endeavors and safeguards the funding needed to continue these pioneering inquiries. Those who support a chair endowment become vital partners in our scientist groundbreaking, lifesaving discoveries. Endowing and naming a chair provides the opportunity to honor a loved one with a memorial that will last for many years. Endowed chairs provide a steady and predictable V 4 flow of funds in perpetuity, allowing the institutions to strengthen the quality of its programs and services beyond levels that other funding sources alone could support. Board designated funds give researchers the funding to initiate new programs for the prevention, detection, and treatment of cancer. The funds assist patients and their families to receive the best support and provide important services to the community XI 8 Network Other support 593,899 and Pension Liability activity Increase of 1,963,866 XII 2d Not Applicable XIII 2d Not Applicable X X X X X X X false NJ NY PA Garden Party 124472 124472 29796 Plain Fancy 47656 47656 12639 2 283033 7748 275285 174225 455161 7748 447413 216660 216660 230753 X X X X X true false false false false false false false false Michael V Seiden MD PhD 492692 38098 15973 546763 Paul F Engstrom MD 429752 1800 2297 15168 449017 Jeff Boyd PhD 363462 58130 2692 19104 443388 J Robert Beck MD 352848 11596 2615 6234 373293 Joseph F Hediger 311527 2308 14787 328622 Gary J Weyhmuller 311538 2308 19237 333083 Susan H Tofani 311496 2308 2819 316623 Mary B Daly MD PhD 329732 15577 2492 7899 355700 Anna Marie Skalka PhD 305785 3404 14070 323259 Jill L Marsteller 230358 4190 2308 11534 248390 Robert C Young 181029 25000 315 2550 9922 218816 R Donald Leedy 173385 2717 176102 Christine Wilson 141795 5077 146872 George R Simon 321923 1000 70 2385 16168 341546 Jose Russo 246640 1827 1764 250231 Joseph R Testa 225588 12607 1671 7274 247140 Suzanne M Miller Halegoua 237095 1756 8169 247020 Sharon L Manne 194577 14179 1441 7775 217972 Dorothy A Riehs 227302 21154 1466 18684 268606 Anthony Diasio 213892 1585 16273 231750 Joanne M Hambleton 207692 1538 2131 211361 Kurt Schwinghammer 181173 1314 1333 183820 Robert Spallone 180324 6571 1720 12657 201272 Thomas K Garvey 19808 27140 103000 1585 1302 152835 Philadelphia Authority for Industrial Development 232237287 7178182F4 2007-09-28 56530000 Imaging Ctr, OR suite, Refunding false false Philadelphia Authority for Industrial Development 232237287 7178182G2 2007-09-28 23645000 Construct 6 level Parking Garage false false Philadelphia Authority for Industrial Development 232237287 7178182H0 2007-09-28 16375000 Refunding false false Philadelphia Authority for Industrial Development 232237287 7178182J6 2007-09-28 27800000 Construct 5 story Cancer Pavilion false false 56530000 2761832 599105 20470320 2009 true false true true 23645000 302769 19432231 2010 true false true true 16375000 191564 2135000 2008 true false true true 27800000 437214 31272786 2010 true false true true false false true true true true false false true true true true false false true true true true false false true true true true true true false true Morgan Stanley 0000000004.328000000000 true false true true false true JP Morgan 0000000018.900000000000 true Morgan Stanley 0000000004.330000000000 true false true true false true JP Morgan 0000000024.900000000000 true Morgan Stanley 0000000004.330000000000 true false true true false true JP Morgan 0000000029.900000000000 true Morgan Stanley 0000000004.330000000000 true false true Peter McCausland - Airgas Board of Director 19823 Acquisition of Specialty gases false X 4 Third party appraisal false true true 990 III 2 In May 2009, Fox Chase launched the Institute for Personalized Medicine, a program aimed at matching emerging targeted drug therapies to the unique genetic profiles of individual patient tumors. Its first ambitious projects focus on understanding the biology of rate types of sarcoma and ovarian cancer. The Institute builds on Fox Chases already substantial annotated Biosample Repository and Tumor Bank to add new layers of knowledge about the genetic information in individual patient tumors. Form 990 III 3 N/A Form 990 III 4d N/A Form 990 V 3a N/A Form 990 VI 2-7b N/A Form 990 VI 8 N/A Form 990 VI 9b N/A Form 990 VI 11a The Form 990 is prepared internally by management and reviewed by several members of the Finance Department including both the Vice President - Finance and the Sr. Vice President - Finance CFO, members of the Senior Leadership Committee and the Audit Committee of the Board of Directors. They are also reviewed by the tax department of the organizations independent auditors. Form 990 VI 12 The organization completed an annual independent audit, but at this time final audit reports have not been issued. The delay is due the organization not meeting financial debt covenants. The organization has engaged a financial consultant team to negotiate terms and conditions that will enable the financial covenants to be met going forward. A letter of forbearance is being requested from the debt holders so final audit statements can be issued. Form 990 VI 12c In the case of potential conflict of interest or commitment, the President of FCCC shall be responsible for administering all matters. All disclosures shall be kept confidential, in a separate file under the control of the Office of the President. They shall not be made part of any personnel record or the basis for any review of the performance of the individual staff member. Access to these records shall be made available only to Board members, the President or his designee or a properly authorized governmental body, acting under statutory or regulatory authority. Records will be maintained for three years unless the materials are subject to governmental action. Disclosures shall be required of all staff and board members as follows Form 990 VI 12c By Board Members - All members of FCCC shall be required to complete a Conflict of Interest Disclosure form at the time of appointment, annually and whenever a new potential conflict arises. By Employees - All scientist, physicians and administrative employees at the management level and above of FCCC shall be required to complete a Conflict of Interest form at the time of employment, annually and whenever a new potential conflict arises and submit such disclosure forms to the Chief Academic Officer or his/her designee. By Consultants and Subcontractors - Consultants and Subcontractors shall certify to FCCC that they are not in a position to influence Center buisiness, research or other decisions in ways that could lead to any form of personal gain from them or their family or give improper advantage to others to the Centers detriment. Form 990 VI 15b The Organizations compensation policy for the positions of CEO, Executive Directors, senior management, officers and or key employees is to utilize a national survey facility for compensation information. It is reviewed by the organizations compensation committee as well as the Board for approval. Form 990 VI 19 The organizations governing documents, conflict of interest policy, and financial statements are made available to the public when requested. Schedule K The Bonds were issued by the Fox Chase Cancer Center, Institute for Cancer Research and American Oncologic Hospital via Master Trust Indentures. Under the terms of the indentures, the bonds are joint and several liabilities of Fox Chase Cancer Center, Institute for Cancer Research and American Oncologic Hospital and may issue additional debt based upon compliance with the terms and conditions prescribed in the Master Indenture. Institute for Cancer Research 333 Cottman Avenue Philadelphia PA 19111 236296135 Research DE 501c3 4 Not Applicable American Oncologic Hospital 333 Cottman Avenue Philadelphia PA 19111 231352156 Patient Care PA 501c3 3 Not Applicable Health Services of Fox Chase Cancer Center 333 Cottman Avenue Philadelphia PA 19111 232328543 Patient Care PA 501c3 3 Not Applicable Fox Chase Network 333 Cottman Avenue Philadelphia PA 19111 232467337 Clinical Services PA 501c3 11b Not Applicable Fox Chase Select 76 ST Paul Street Burlington VT 05401 020597423 Captive Insurance VT 501c3 11a Not Applicable Fox Chase Limited 333 Cottman Avenue Philadelphia PA 19111 232396731 Medical Services PA Not Applicable C Corp 1.00000 false false false false false false false false false false false false true true true true false false Fox Chase Cancer Center 333 Cottman Avenue Philadelphia PA 191112497 232003072 X 0 10600 10600 53894495 53905095 160726 40182 0 0 0 Institute for Cancer Research 333 Cottman Avenue Philadelphia PA 191112497 236296135 0 5969 5969 33472350 33478319 99821 24955 0 0 0 American Oncologic Hospital 333 Cottman Avenue Philadelphia PA 191112497 231352156 0 30452 30452 203997598 204028050 608340 152085 0 0 0 Health Services of FCCC 333 Cottman Avenue Philadelphia PA 191112497 232328543 0 3263 3263 41973020 41976283 125158 31290 0 0 0 Fox Chase Network 333 Cottman Avenue Philadelphia PA 191112497 232467337 0 0 0 1997320 1997320 5955 1489 0 0 0